ITGAL/CD11a rHu IgG1k mAb (Ref: Efalizumab)
Application
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Reactivity
Human, Rhesus
Target
| Target Name | Integrin aL / ITGAL / CD11a |
| Target Uniprot | P20701 |
Overview
| Catalog# | BIO0687SM |
| Product Name | Anti-human Integrin aL / ITGAL / CD11a (Efalizumab Biosimilar) |
Specifications
| Conjugation | None |
| Formulation | 100 mM Pro-Ac 20mM Arg pH 5.0 |
| Storage | For long term storage, the produce should be stored at -20℃ or lower. |
| Reconstitution | Dissolve with sterile ddH2O |
| Concentration | Lot Dependent |
| Isotype | Human IgG1 |
| Calculated M.W. | 146.14 kDa |
| Endotoxin | <0.001 EU/ug |
| Expression System | CHO |
| Purification | Protein A |
Frequently asked questions
Which applications is ITGAL/CD11a rHu IgG1k mAb (Ref: Efalizumab) (BIO0687SM) validated for, and at what dilution?
BIO0687SM is validated for In Vivo Research.